Last updated on January 2018

Rosacea Study

Brief description of study

To assess the efficacy and safety of FMX103 1.5% minocycline foam applied topically once daily for 12 weeks in the treatment of rosacea.

Clinical Study Identifier: TX155534

Contact Investigators or Research Sites near you

Start Over

Sarah Fairbanks

Clinical Trials Management, LLC
Metairie, LA USA
  Connect »